Background The prognostic value of regadenoson SPECT myocardial perfusion imaging
(MPI) has not been specifically studied in patients with end-stage renal disease (ESRD) …

Abstracts Background An AHA/ACCF scientific statement proposed 8 risk factors to assess
the need for noninvasive coronary artery disease (CAD) surveillance in asymptomatic …

Background Blunted heart rate response (HRR) to vasodilator stress agents is associated
with worse outcomes. There are limited data assessing the effect of impaired HRR to …

Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …

Background The significance of post-stress decrease in left ventricular ejection fraction
(LVEF) with regadenoson stress gated SPECT (GSPECT) myocardial perfusion imaging …

Background In patients undergoing regadenoson SPECT myocardial perfusion imaging
(MPI), the prognostic value of ischemic ST-segment depression (ST↓) and the optimal ST↓ …

Background Data on the prognostic value of regadenoson SPECT myocardial perfusion
imaging (MPI) is limited and based on small cohorts. Methods and Results We conducted a …

Background Data on the diagnostic and prognostic value of subtle abnormalities on
myocardial perfusion imaging (MPI) are limited. Methods and results In a retrospective …

Background In asymptomatic end-stage renal disease (ESRD) patients undergoing
vasodilator stress myocardial perfusion imaging (MPI) prior to renal transplantation (RT), the …

Background Vasodilator stress myocardial perfusion imaging (MPI) is the provocative test of
choice in patients with left bundle branch block (LBBB) or ventricular paced (V-paced) …